Owkin will bring its world-class data access and AI to the forefront of drug discovery and development, analysing multimodal patient data in a privacy-enhanced...
AQEMIA, a leading company in generative-AI-driven drug discovery, announces the achievement of a research milestone in its collaboration with Servier, an international independent pharmaceutical...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for systemic lupus erythematosus...
Exscientia plc announced the appointment of two technology and clinical development leaders to senior roles to significantly strengthen the impact of differentiating technology applications...
Inspired Chemistry™ platform eliminates manual chemical synthesis as a key bottleneck in drug discovery with automated high-throughput, multi-step synthesis to enable more complex and...
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced the completion of BioHive-2, Recursion’s new NVIDIA DGX SuperPOD AI supercomputer,...